GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hwail Pharm Co Ltd (XKRX:061250) » Definitions » Selling and Marketing Expense

Hwail Pharm Co (XKRX:061250) Selling and Marketing Expense : ₩1,091 Mil (TTM As of Mar. 2024)


View and export this data going back to 2002. Start your Free Trial

What is Hwail Pharm Co Selling and Marketing Expense?

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services. Hwail Pharm Co's Selling and Marketing Expense for the three months ended in Mar. 2024 was ₩298 Mil. Its Selling and Marketing Expense for the trailing twelve months (TTM) ended in Mar. 2024 was ₩1,091 Mil.

Hwail Pharm Co Selling and Marketing Expense Historical Data

The historical data trend for Hwail Pharm Co's Selling and Marketing Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hwail Pharm Co Selling and Marketing Expense Chart

Hwail Pharm Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Selling and Marketing Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,086.52 1,673.48 1,030.11 1,273.27 1,113.33

Hwail Pharm Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Selling and Marketing Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 319.91 303.96 280.87 208.59 297.73

Hwail Pharm Co Selling and Marketing Expense Calculation

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services.

Selling and Marketing Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩1,091 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hwail Pharm Co Selling and Marketing Expense Related Terms

Thank you for viewing the detailed overview of Hwail Pharm Co's Selling and Marketing Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Hwail Pharm Co (XKRX:061250) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hwail Pharm Co Ltd (XKRX:061250) » Definitions » Selling and Marketing Expense
Comparable Companies
XKRX:006620 XKRX:003120 XKRX:002210 XKRX:389470 XKRX:002620 XKRX:176750 XKRX:214390 XKRX:054670 XKRX:023910 XKRX:330350 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
904-7, Sangsin-Ri, Hyangnam-Eup, Hwaseong, Gyeonggi, KOR, 445-746
Website
http://www.hwail.com
Hwail Pharm Co Ltd is engaged in manufacturing and distribution of raw materials used in pharmaceutical production. Its products include antitussive expectorants, spasmolytic, stomach function modifier, anti-inflammatory, and others.

Hwail Pharm Co (XKRX:061250) Headlines

No Headlines